Novartis Investigative Site
Rosebank 2196
0 studies enrolling now · 4 studies all time
What they study most
Relapsing Forms of Multiple Sclerosis, Relapsing Multiple Scelrosis, Relapsing Multiple Sclerosis
Studies at this site
- Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
- Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS — Running, not enrolling
- Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. — Completed
- Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed